cordycepin has been researched along with Innate Inflammatory Response in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 13 (59.09) | 24.3611 |
| 2020's | 9 (40.91) | 2.80 |
| Authors | Studies |
|---|---|
| Edwards, BS; Graves, SW; Saunders, MJ; Sklar, LA; Zhu, J | 1 |
| Chu, PM; Ho, TJ; Hsieh, PL; Huang, CY; Ku, CW; Ou, HC | 1 |
| Ashraf, S; de Moor, CH; Hafeez, A; Khamis, AS; Lawrence, S; McWilliams, D; Radhi, M; Thomas, R; Tranholm, AA; Wellham, PAD | 1 |
| Chen, J; Guo, N; Li, H; Qu, K; Wang, M; Xu, R; Zhang, P; Zhu, H | 1 |
| Pan, Y; Zha, Z; Zheng, Z; Zhou, M | 1 |
| Almutairi, BO; Arockiaraj, J; Arokiyaraj, S; Murugan, R; Priya, PS; Shanjeev, P | 1 |
| Luo, S; Luo, Y; Mo, J; Pang, H; Ren, Z; Wang, K; Wang, X; Wei, J; Xi, D; Yang, R | 1 |
| Ding, C; Ding, X; Dou, M; Han, F; Li, Y; Tian, P; Wang, Y; Xu, C; Xue, W; Zheng, J | 1 |
| Shi, J; Yang, J; Zhou, Y | 1 |
| Chen, AQ; He, SM; Liu, W; Ren, DL; Sun, S; Tang, LS; Yao, LN; Zhang, L | 1 |
| Hylemon, PB; Li, YZ; Yang, J; Zhang, LY; Zhou, HP | 1 |
| Hwang, IH; Jang, HJ; Jang, IS; Jo, E; Joo, JC; Lee, KB; Lee, MY; Oh, SY; Park, SJ; Yoo, HS | 1 |
| Feng, Q; Lei, J; Li, Y; Song, P; Wei, Y; Xu, G; Zhang, T | 1 |
| Guan, J; Kan, H; Li, M; Sun, H; Wang, D; Wang, H; Wang, Y; Zhou, S | 1 |
| Hou, XJ; Li, J; Wang, FZ; Zhong, LP; Zhu, HB | 1 |
| Kim, MI; Kwon, HK; Lee, HJ; Park, HJ; Park, TS; Song, MJ | 1 |
| Ashraf, S; Burston, JJ; Chapman, V; de Moor, CH; Gandhi, RD; Gowler, P; Piccinini, AM; Radhi, M; Thorn, GJ; Walsh, DA | 1 |
| Lei, W; Qi, W; Wang, ZL; Zhang, DW; Zhao, GY | 1 |
| Juan, D; Shihai, Y; Tianzhu, Z | 1 |
| Ge, H; Jin, X; Peng, J; Qu, X; Wang, P | 1 |
| Cao, Y; Jiang, T; Li, Z; Lv, Z; Wang, L; Yang, J | 1 |
| Barthet-Barateig, A; De Moor, CH; Khurshid, A; Knox, AJ; Kondrashov, A; Meijer, HA; Pang, L; Parker, HN; Sicard, M; Tessier, S | 1 |
1 review(s) available for cordycepin and Innate Inflammatory Response
| Article | Year |
|---|---|
A Systematic Review of the Biological Effects of Cordycepin.
Topics: Animals; Antineoplastic Agents; Brain Diseases; Deoxyadenosines; Humans; Inflammation; Metabolic Diseases; Neoplasms; Signal Transduction | 2021 |
21 other study(ies) available for cordycepin and Innate Inflammatory Response
| Article | Year |
|---|---|
Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
Topics: Animals; Biotinylation; Flow Cytometry; Fluorescence Resonance Energy Transfer; Green Fluorescent Proteins; High-Throughput Screening Assays; Humans; Inflammation; Kinetics; Microspheres; Peptide Hydrolases; Peptides; Reproducibility of Results; Temperature | 2010 |
Cordycepin Attenuates Palmitic Acid-Induced Inflammation and Apoptosis of Vascular Endothelial Cells through Mediating PI3K/Akt/eNOS Signaling Pathway.
Topics: Apoptosis; Cell Line; Cordyceps; Deoxyadenosines; Endothelial Cells; Humans; Inflammation; Molecular Structure; Nitric Oxide Synthase Type III; Palmitic Acid; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt | 2021 |
Cordycepin alleviated metabolic inflammation in Western diet-fed mice by targeting intestinal barrier integrity and intestinal flora.
Topics: Animals; Deoxyadenosines; Diet, High-Fat; Diet, Western; Gastrointestinal Microbiome; Inflammation; Lipopolysaccharides; Mice; Mice, Inbred C57BL; Obesity | 2022 |
Cordycepin suppresses vascular inflammation, apoptosis and oxidative stress of arterial smooth muscle cell in thoracic aortic aneurysm with VEGF inhibition.
Topics: Angiotensin II; Animals; Aortic Aneurysm, Thoracic; Apoptosis; Calcium Chloride; Humans; Inflammation; Interleukin-6; Myocytes, Smooth Muscle; Oxidative Stress; Rats; Vascular Endothelial Growth Factor A | 2023 |
Delineating the protective action of cordycepin against cadmium induced oxidative stress and gut inflammation through downregulation of NF-κB pathway.
Topics: Animals; Cadmium; Down-Regulation; Inflammation; Larva; NF-kappa B; Oxidative Stress; Zebrafish | 2023 |
Cordycepin Attenuates IFN-γ-Induced Macrophage IP-10 and Mig Expressions by Inhibiting STAT1 Activity in CFA-Induced Inflammation Mice Model.
Topics: Animals; Antineoplastic Agents; Chemokine CXCL10; Chemokine CXCL9; Deoxyadenosines; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Freund's Adjuvant; Gene Expression; Inflammation; Interferon-gamma; Macrophages; Mice; Random Allocation; RAW 264.7 Cells; STAT1 Transcription Factor | 2020 |
Cordycepin protects renal ischemia/reperfusion injury through regulating inflammation, apoptosis, and oxidative stress.
Topics: Animals; Apoptosis; Blood Urea Nitrogen; Deoxyadenosines; Humans; Inflammation; Kidney Diseases; Oxidative Stress; Protective Agents; Rats; Reperfusion Injury | 2020 |
Cordycepin protects against acute pancreatitis by modulating NF-κB and NLRP3 inflammasome activation via AMPK.
Topics: Acute Disease; AMP-Activated Protein Kinases; Animals; Biomarkers; Cytokines; Deoxyadenosines; Disease Models, Animal; Inflammasomes; Inflammation; Inflammation Mediators; Male; Mice; Mice, Inbred ICR; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Pancreatitis; Protective Agents | 2020 |
Cordycepin inhibits inflammatory responses through suppression of ERK activation in zebrafish.
Topics: Animals; Anti-Inflammatory Agents; Cytokines; Deoxyadenosines; Extracellular Signal-Regulated MAP Kinases; Inflammation; Lipopolysaccharides; Neutrophil Infiltration; Neutrophils; Phosphorylation; Zebrafish; Zebrafish Proteins | 2021 |
Cordycepin inhibits LPS-induced inflammatory responses by modulating NOD-Like Receptor Protein 3 inflammasome activation.
Topics: Animals; Anti-Inflammatory Agents; Blotting, Western; Cyclooxygenase 2; Cytokines; Deoxyadenosines; Dose-Response Relationship, Drug; Humans; Inflammasomes; Inflammation; Lipopolysaccharides; Macrophages; MAP Kinase Signaling System; Mice; NLR Family, Pyrin Domain-Containing 3 Protein; RAW 264.7 Cells; Real-Time Polymerase Chain Reaction; Signal Transduction | 2017 |
Cordycepin promotes apoptosis in renal carcinoma cells by activating the MKK7-JNK signaling pathway through inhibition of c-FLIPL expression.
Topics: Animals; Antigens, Differentiation; Apoptosis; bcl-2-Associated X Protein; Carcinoma, Renal Cell; CASP8 and FADD-Like Apoptosis Regulating Protein; Cell Line, Tumor; Cell Movement; Cell Survival; Deoxyadenosines; Gene Expression Regulation, Neoplastic; HEK293 Cells; Humans; Inflammation; JNK Mitogen-Activated Protein Kinases; Kidney Neoplasms; Male; MAP Kinase Kinase 7; MAP Kinase Signaling System; Mice, Inbred BALB C; Mice, Nude; NF-kappa B; Nitric Oxide; Phosphorylation; Promoter Regions, Genetic; Tumor Necrosis Factor-alpha; Up-Regulation | 2017 |
Cordycepin inhibits LPS-induced acute lung injury by inhibiting inflammation and oxidative stress.
Topics: Acute Lung Injury; Animals; Deoxyadenosines; Gene Expression Regulation, Enzymologic; Heme Oxygenase-1; Inflammation; Interleukin-1beta; Lipopolysaccharides; Male; Malondialdehyde; Membrane Proteins; Mice; Mice, Inbred BALB C; NF-E2-Related Factor 2; NF-kappa B; Oxidative Stress; Tumor Necrosis Factor-alpha | 2018 |
Cordycepin rescues lidocaine-induced neurotoxicity in dorsal root ganglion by interacting with inflammatory signaling pathway MMP3.
Topics: Animals; Apoptosis; Deoxyadenosines; Down-Regulation; Ganglia, Spinal; Gene Expression Regulation, Enzymologic; Inflammation; Lidocaine; Matrix Metalloproteinase 3; Neurons; Rats; Signal Transduction | 2018 |
[Protective effect and underlying mechanism of cordycepin on non-alcoholic fatty liver in ob/ob mice].
Topics: Administration, Oral; Animals; Blood Glucose; Body Weight; Deoxyadenosines; Inflammation; Insulin Resistance; Lipid Metabolism; Lipids; Lipogenesis; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Non-alcoholic Fatty Liver Disease; Triglycerides | 2017 |
Topics: Adenosine; Animals; Anti-Inflammatory Agents; Cordyceps; Deoxyadenosines; Dermatitis, Contact; Down-Regulation; Fermentation; Flavonoids; I-kappa B Proteins; Inflammation; Inflammation Mediators; Interleukin-1beta; Lipopolysaccharides; Macrophages; Mice; Mice, Inbred BALB C; Mitogen-Activated Protein Kinases; Nitric Oxide; Nitric Oxide Synthase Type II; Pediococcus pentosaceus; Phosphorylation; Polyphenols; RAW 264.7 Cells; RNA, Messenger; Transcription Factor RelA; Tumor Necrosis Factor-alpha | 2018 |
The polyadenylation inhibitor cordycepin reduces pain, inflammation and joint pathology in rodent models of osteoarthritis.
Topics: Animals; Arthritis, Experimental; Deoxyadenosines; Disease Models, Animal; Humans; Inflammation; Joints; Mice; NF-kappa B; Osteoarthritis; Pain; Polyadenylation; Rats; Signal Transduction | 2019 |
Cordycepin (3'-deoxyadenosine) down-regulates the proinflammatory cytokines in inflammation-induced osteoporosis model.
Topics: Aldehydes; Animals; Collagen Type I; Cytokines; Deoxyadenosines; Down-Regulation; Inflammation; Interleukin-1beta; Liver; Neutrophils; Nitric Oxide; Osteoporosis; Rats; Tumor Necrosis Factor-alpha | 2014 |
The effects of cordycepin on ovalbumin-induced allergic inflammation by strengthening Treg response and suppressing Th17 responses in ovalbumin-sensitized mice.
Topics: Animals; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Bronchoalveolar Lavage Fluid; Deoxyadenosines; Dexamethasone; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Eosinophilia; Eosinophils; Female; Forkhead Transcription Factors; Immunoglobulin E; Inflammation; Interleukin-10; Interleukin-17; Mice; Mice, Inbred BALB C; Nuclear Receptor Subfamily 1, Group F, Member 3; Ovalbumin; Random Allocation; T-Lymphocytes, Regulatory; Th17 Cells | 2015 |
Effects of cordycepin on the microglia-overactivation-induced impairments of growth and development of hippocampal cultured neurons.
Topics: Animals; Cell Death; Cell Proliferation; Cell Survival; Cells, Cultured; Culture Media, Conditioned; Deoxyadenosines; Dose-Response Relationship, Drug; Growth Cones; Hippocampus; Inflammation; Lipopolysaccharides; Mice; Microglia; Neurites; Neurogenesis; Neurons; Neuroprotection; NF-kappa B; Signal Transduction | 2015 |
Cordycepin protected against the TNF-α-induced inhibition of osteogenic differentiation of human adipose-derived mesenchymal stem cells.
Topics: Adipose Tissue; Anti-Inflammatory Agents; Cell Death; Cell Differentiation; Cells, Cultured; Core Binding Factor Alpha 1 Subunit; Deoxyadenosines; Humans; Inflammation; Mesenchymal Stem Cells; NF-kappa B; NF-KappaB Inhibitor alpha; Osteogenesis; Phosphorylation; Protective Agents; RNA, Messenger; Signal Transduction; Sp7 Transcription Factor; Transcription Factors; Tumor Necrosis Factor-alpha | 2015 |
Inhibition of polyadenylation reduces inflammatory gene induction.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Line; Chemokine CCL2; Chemokine CXCL1; Deoxyadenosines; DNA-Directed RNA Polymerases; Gene Expression; HeLa Cells; Humans; Inflammation; Inflammation Mediators; Interleukin-8; Mice; Myocytes, Smooth Muscle; NF-kappa B; NIH 3T3 Cells; Polyadenylation; Promoter Regions, Genetic; Respiratory Muscles; RNA Stability; RNA, Messenger; Tumor Necrosis Factor-alpha | 2012 |